INTERNATIONAL PATENT: CORCEPT THERAPEUTICS INCORPORATED FILES APPLICATION FOR "CONCOMITANT ADMINISTRATION OF CYP3A4 INDUCERS AND MIFEPRISTONE"

GENEVA, March 24 -- CORCEPT THERAPEUTICS INCORPORATED (101 Redwood Shores ParkwayRedwood City, California 94065) filed a patent application (PCT/US2025/045547) for "CONCOMITANT ADMINISTRATION OF CYP3A4 INDUCERS AND MIFEPRISTONE" on Sep 09, 2025. With publication no. WO/2026/059904, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MORAITIS, Andreas (c/o Corcept Therapeutics Incorporated101 Redwood Shores ParkwayRedwood City, California 94065), BELANOFF, Joseph (c/o Corcept Therapeutics Incorporated101 Redwood Shores Parkway...